News On-skin printing of sensors could monitor COVID-19 symptoms Scientists say on-skin printing could be used to create on-body sensors to monitor physiological signals and devices to wirelessly transmit the data.
News Wearables still lack evidence of patient outcomes Out of 4,000 studies, review found only 16 were high quality.
News NICE backs first targeted therapy for ALK+ lung cancer Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first targeted therapy for this indication.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.